C

CG Oncology

43 employees

CG Oncology is a clinical-stage biopharmaceutical company focused on the development of oncolytic immunotherapies to combat cancer.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Diagnostics
Health Care
Immuno-Oncology

Date founded

2010

Funding rounds raised

Total raised

$120M

from 28 investors over 28 rounds

C

CG Oncology raised $105M on August 2, 2023

Investors: Decheng Capital, Foresite Capital, Malin Corporation plc, Longitude Capital, TCG X, Avidity Partners and RA Capital Management, L.P.

C

CG Oncology raised $105M on August 2, 2023

Investors: Decheng Capital, Avidity Partners, TCG X, Foresite Capital, RA Capital Management, L.P., Malin Corporation plc and Longitude Capital

C

CG Oncology raised $120M on November 15, 2022

Investors: RA Capital Management, L.P., Acorn Bioventures, ORI Capital Limited, Sirona Capital, Longitude Capital and Decheng Capital

C

CG Oncology raised $47M on December 10, 2020

Investors: Perseverance Capital Management, ORI Capital Limited, Camford Capital and Kissei Pharmaceutical Co Ltd

C

CG Oncology raised $22M on March 18, 2019

Investors: ORI Capital Limited and Perseverance Capital Management

C

CG Oncology raised $10M on August 5, 2015

Investors: WI Harper Group

C

CG Oncology raised $14M on July 29, 2014

Investors: DHVC

FAQ